Growth Metrics

Verastem (VSTM) Share-based Compensation (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.04%
Dec 31, 2025 -7.02%
Sep 30, 2025 -36.19%
Jun 30, 2025 90.88%
Mar 31, 2025 -11.44%
Dec 31, 2024 4.34%
Sep 30, 2024 1.57%
Jun 30, 2024 28.46%
Mar 31, 2024 -7.20%
Dec 31, 2023 5.34%
Sep 30, 2023 5.94%
Jun 30, 2023 9.06%
Mar 31, 2023 2.02%
Dec 31, 2022 -5.09%
Sep 30, 2022 -22.87%
Jun 30, 2022 6.80%
Mar 31, 2022 4.57%
Dec 31, 2021 -20.79%
Sep 30, 2021 -8.43%
Jun 30, 2021 9.60%
Mar 31, 2021 -32.49%
Dec 31, 2020 486.60%
Sep 30, 2020 -69.86%
Jun 30, 2020 21.09%
Mar 31, 2020 4.50%
Dec 31, 2019 1,211.00%
Mar 31, 2019 27.51%
Dec 31, 2018 781.50%
Sep 30, 2018 0.00%
Jun 30, 2018 -84.94%
Mar 31, 2018 37.90%
Dec 31, 2017 154.09%
Sep 30, 2017 -68.76%
Jun 30, 2017 1.34%
Mar 31, 2017 126.37%
Dec 31, 2016 -447.36%
Sep 30, 2016 -24.32%
Jun 30, 2016 1.23%
Mar 31, 2016 -16.33%
Dec 31, 2015 -14.15%
Sep 30, 2015 -6.39%
Jun 30, 2015 -19.05%
Mar 31, 2015 53.78%
Dec 31, 2014 -35.59%
Sep 30, 2014 8.17%
Jun 30, 2014 -26.60%
Mar 31, 2014 64.87%
Dec 31, 2013 -13.49%
Sep 30, 2013 3.90%
Jun 30, 2013 7.86%
Mar 31, 2013 -10.10%
Dec 31, 2012 71.70%
Sep 30, 2012 8.90%
Jun 30, 2012 -3.01%
Mar 31, 2012 71.22%
Dec 31, 2011 37.17%
Sep 30, 2011 1,659.46%
Jun 30, 2011 -31.48%